GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (FRA:7AC) » Definitions » DeferredTaxAndRevenue

Acarix AB (FRA:7AC) DeferredTaxAndRevenue : €0.00 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Acarix AB DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Acarix AB's current deferred tax and revenue for the quarter that ended in Mar. 2025 was €0.00 Mil.

Acarix AB DeferredTaxAndRevenue Historical Data

The historical data trend for Acarix AB's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acarix AB DeferredTaxAndRevenue Chart

Acarix AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Acarix AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Acarix AB DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Acarix AB's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Acarix AB Business Description

Traded in Other Exchanges
Address
Hyllie Boulevard 34, 5TR, c/o Regus Hyllie, Malmo, SWE, 215 32
Acarix AB is a Swedish medical technology company that develops solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics.

Acarix AB Headlines

No Headlines